Upload
Featured Recent Articles Topics Login Upload

Search Results for 'adverse aes'

adverse aes published presentations and documents on DocSlides.

Lessons to learn from the reporting of adverse events in RCTs published in four high impact journal
Lessons to learn from the reporting of adverse events in RCTs published in four high impact journal
by phoebe-click
Rachel Phillips & Victoria Cornelius. Review....
Adverse Events
Adverse Events
by sherrill-nordquist
, Unanticipated . Problems, and Protocol Deviatio...
AE/SAE/EAE Identification and Reporting
AE/SAE/EAE Identification and Reporting
by giovanna-bartolotta
. Presentation Overview. PSRT queries. Safety Ph...
Adverse Events , Unanticipated
Adverse Events , Unanticipated
by summer
Problems, and Protocol Deviations. Kathleen O’Ma...
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
by lois-ondreau
S. Percy Ivy, MD. Associate Chief, Senior Investi...
Remote Monitoring of Adverse Events
Remote Monitoring of Adverse Events
by conchita-marotz
Dee Blumberg, PhD. An adverse event (AE) is any u...
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
by mitsue-stanley
S. Percy Ivy, MD. Associate Chief, Senior Investi...
Academy for Research Professionals
Academy for Research Professionals
by josephine
2019 Spring. SAFETY of the SUBJECT. Safety of the...
Unanticipated Problems
Unanticipated Problems
by pamella-moone
15. th. FERCAP International Conference. 24 Nov ...
FDA Final Rule & Revised CTEP Guidelines for Expedited
FDA Final Rule & Revised CTEP Guidelines for Expedited
by stefany-barnette
S. Percy Ivy, MD. Associate Chief, Senior Investi...
Adverse Event Documentation: AE Log and GAE Log CRF Completion
Adverse Event Documentation: AE Log and GAE Log CRF Completion
by stefany-barnette
Training Binder pages 269 - 272. . Reportable AE...
Evaluation of tolerability, pharmacokinetics, and anti-
Evaluation of tolerability, pharmacokinetics, and anti-
by pamella-moone
r. etroviral activity of MK-8591 in treatment-na...
Estimated costs of managing treatment-related adverse
Estimated costs of managing treatment-related adverse
by lindy-dunigan
eventsof. . nivolumab. and . docetaxel. in the...
Guidance onUnanticipated Problems (UPs) and Adverse Events (AEs)
Guidance onUnanticipated Problems (UPs) and Adverse Events (AEs)
by ellena-manuel
Bertha deLandaIRB Training SpecialistResearch Comp...
A Phase
A Phase
by giovanna-bartolotta
Ia. Study to Assess the Safety and Immunogenicit...